Several oncogenic signaling pathways have been implicated in the biology of cartilaginous neoplasms and in progressions such as those related to cell migration (IMP3) and cell cycle (CDK4, MDM2, and β-catenin) .5 This evidence concerns the gene MDM2 and chondrogenic neoplasm.